We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 31, 2020

Cabazitaxel in Advanced Gastroesophageal Cancer

Clinical Cancer Research


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Cancer Research
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor Associated Macrophages With Patient Outcome
Clin. Cancer Res 2020 Jul 08;[EPub Ahead of Print], MA Shah, P Enzinger, AH Ko, AJ Ocean, PA Philip, PV Thakkar, K Cleveland, Y Lu, J Kortmansky, PJ Christos, C Zhang, N Kaur, D Elmonshed, G Galletti, S Sarkar, B Bhinder, ME Pittman, OM Plotnikova, N Kotlov, FE Frenkel, AV Bagaev, O Elemento, D Betel, P Giannakakou, HJ Lenz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading